NCT05934253View on ClinicalTrials.gov

The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

January 15, 2024

Study Completion Date

February 15, 2024

Conditions
AntisepticAnesthesia, Local
Interventions
DRUG

Chloroprocaine ophthalmic gel 3%

FDA approved topical ophthalmic anesthetic applied 3 drops to the ocular surface before the planned procedure.

Trial Locations (1)

33511

Brandon Eye Associates, Brandon

All Listed Sponsors
lead

Harrow Inc

INDUSTRY